171 related articles for article (PubMed ID: 21281818)
1. Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.
Mannelqvist M; Stefansson IM; Bredholt G; Hellem Bø T; Oyan AM; Jonassen I; Kalland KH; Salvesen HB; Akslen LA
Am J Pathol; 2011 Feb; 178(2):861-71. PubMed ID: 21281818
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.
Bredholt G; Mannelqvist M; Stefansson IM; Birkeland E; Bø TH; Øyan AM; Trovik J; Kalland KH; Jonassen I; Salvesen HB; Wik E; Akslen LA
Oncotarget; 2015 Nov; 6(37):39676-91. PubMed ID: 26485755
[TBL] [Abstract][Full Text] [Related]
3. Gene alterations in tumor-associated endothelial cells from endometrial cancer.
Du XL; Jiang T; Zhao WB; Wang F; Wang GL; Cui M; Wen ZQ
Int J Mol Med; 2008 Nov; 22(5):619-32. PubMed ID: 18949382
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Wik E; Trovik J; Kusonmano K; Birkeland E; Raeder MB; Pashtan I; Hoivik EA; Krakstad C; Werner HM; Holst F; Mjøs S; Halle MK; Mannelqvist M; Mauland KK; Oyan AM; Stefansson IM; Petersen K; Simon R; Cherniack AD; Meyerson M; Kalland KH; Akslen LA; Salvesen HB
Gynecol Oncol; 2014 Sep; 134(3):599-606. PubMed ID: 24995579
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis related gene expression profiles of human endometrial endothelial cells isolated from tissue of endometrial cancer].
Du XL; Sheng XG; Yan CX; Liu T; Wang C; Song QQ; Li QS
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):756-63. PubMed ID: 23302734
[TBL] [Abstract][Full Text] [Related]
6. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
[TBL] [Abstract][Full Text] [Related]
7. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.
Muinelo-Romay L; Colas E; Barbazan J; Alonso-Alconada L; Alonso-Nocelo M; Bouso M; Curiel T; Cueva J; Anido U; Forteza J; Gil-Moreno A; Reventos J; Lopez-Lopez R; Abal M
Mol Cancer Ther; 2011 Aug; 10(8):1357-66. PubMed ID: 21613448
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
9. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Engelsen IB; Mannelqvist M; Stefansson IM; Carter SL; Beroukhim R; Øyan AM; Otte AP; Kalland KH; Akslen LA; Salvesen HB
Br J Cancer; 2008 May; 98(10):1662-9. PubMed ID: 18475299
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
Ann Oncol; 2002 Oct; 13(10):1605-11. PubMed ID: 12377649
[TBL] [Abstract][Full Text] [Related]
12. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
13. Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.
Opławski M; Michalski M; Witek A; Michalski B; Zmarzły N; Jęda-Golonka A; Styblińska M; Gola J; Kasprzyk-Żyszczyńska M; Mazurek U; Plewka A
Mol Med Rep; 2017 Sep; 16(3):2547-2555. PubMed ID: 28656251
[TBL] [Abstract][Full Text] [Related]
14. Benzotriazole Enhances Cell Invasive Potency in Endometrial Carcinoma Through CTBP1-Mediated Epithelial-Mesenchymal Transition.
Wang Y; Dai C; Zhou C; Li W; Qian Y; Wen J; Wang Y; Han B; Ma J; Xu J; Fu Z; Ruan H; Tong H; Jia X
Cell Physiol Biochem; 2017; 44(6):2357-2367. PubMed ID: 29262396
[TBL] [Abstract][Full Text] [Related]
15. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
16. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Salvesen HB; Carter SL; Mannelqvist M; Dutt A; Getz G; Stefansson IM; Raeder MB; Sos ML; Engelsen IB; Trovik J; Wik E; Greulich H; Bø TH; Jonassen I; Thomas RK; Zander T; Garraway LA; Oyan AM; Sellers WR; Kalland KH; Meyerson M; Akslen LA; Beroukhim R
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4834-9. PubMed ID: 19261849
[TBL] [Abstract][Full Text] [Related]
18. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
19. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125
[TBL] [Abstract][Full Text] [Related]
20. Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Wik E; Ræder MB; Krakstad C; Trovik J; Birkeland E; Hoivik EA; Mjos S; Werner HM; Mannelqvist M; Stefansson IM; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 Mar; 19(5):1094-105. PubMed ID: 23319822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
